Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Baud-Camus, F; Marquet, P; Soursac, M; Davrinche, C; Farinotti, R
   Determination of N-acetylation phenotype using caffeine as a metabolic probe and high-performance liquid chromatography with either ultraviolet detection or electrospray mass spectrometry
   JOURNAL OF CHROMATOGRAPHY B
   
   F. Baud-Camus et al., "Determination of N-acetylation phenotype using caffeine as a metabolic probe and high-performance liquid chromatography with either ultraviolet detection or electrospray mass spectrometry", J CHROMAT B, 760(1), 2001, pp. 55-63
2. Veau, C; Leroy, C; Banide, H; Auchere, D; Tardivel, S; Farinotti, R; Lacour, B
   Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion
   NEPHROLOGY DIALYSIS TRANSPLANTATION
   
   C. Veau et al., "Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion", NEPH DIAL T, 16(8), 2001, pp. 1607-1614
3. Hiep, BT; Fernandez, C; Tod, M; Banide, H; Thuillier, A; Lacour, B; Farinotti, R; Gimenez, F
   Intestinal absorption and metabolism of chlorpheniramine enantiomers in rat
   CHIRALITY
   
   B.T. Hiep et al., "Intestinal absorption and metabolism of chlorpheniramine enantiomers in rat", CHIRALITY, 13(4), 2001, pp. 207-213
4. Forestier, F; de Renty, P; Peytavin, G; Dohin, E; Farinotti, R; Mandelbrot, L
   Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model
   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
   
   F. Forestier et al., "Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model", AM J OBST G, 185(1), 2001, pp. 178-181
5. Mandelbrot, L; Peytavin, G; Firtion, G; Farinotti, R
   Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women
   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
   
   L. Mandelbrot et al., "Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women", AM J OBST G, 184(2), 2001, pp. 153-158
6. Hiep, B; Fernandez, C; Khanh, V; Hung, NK; Thuillier, A; Farinotti, R; Arnaud, P; Gimenez, F
   Stereospecific versus nonstereospecific assessments for the bioequivalenceof two formulations of racemic chlorpheniramie
   CHIRALITY
   
   B. Hiep et al., "Stereospecific versus nonstereospecific assessments for the bioequivalenceof two formulations of racemic chlorpheniramie", CHIRALITY, 12(8), 2000, pp. 599-605
7. Joly-Guillou, ML; Wolff, M; Farinotti, R; Bryskier, A; Carbon, C
   In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia
   Journal of antimicrobial chemotherapy
   
   M.L. Joly-Guillou et al., "In vivo activity of levofloxacin alone or in combination with imipenem or amikacin in a mouse model of Acinetobacter baumannii pneumonia", J ANTIMICRO, 46(5), 2000, pp. 827-830
8. Pham, YT; Regina, A; Farinotti, R; Couraud, PO; Wainer, IW; Roux, F; Gimenez, F
   Interactions of racemic mefloquine and its enantiomers with P-glycoproteinin an immortalised rat brain capillary endothelial cell line, GPNT
   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
   
   Y.T. Pham et al., "Interactions of racemic mefloquine and its enantiomers with P-glycoproteinin an immortalised rat brain capillary endothelial cell line, GPNT", BBA-GEN SUB, 1524(2-3), 2000, pp. 212-219
9. Aboubakar, M; Couvreur, P; Pinto-Alphandary, H; Gouritin, B; Lacour, B; Farinotti, R; Puisieux, F; Vauthier, C
   Insulin-loaded nanocapsules for oral administration: In vitro and in vivo investigation
   DRUG DEVELOPMENT RESEARCH
   
   M. Aboubakar et al., "Insulin-loaded nanocapsules for oral administration: In vitro and in vivo investigation", DRUG DEV R, 49(2), 2000, pp. 109-117
10. Berlioz, F; Lepere-Prevot, B; Julien, S; Tsocas, A; Carbon, C; Roze, C; Farinotti, R
    Chronic nifedipine dosing enhances cephalexin bioavailability and intestinal absorption in conscious rats
    DRUG METABOLISM AND DISPOSITION
    
    F. Berlioz et al., "Chronic nifedipine dosing enhances cephalexin bioavailability and intestinal absorption in conscious rats", DRUG META D, 28(11), 2000, pp. 1267-1269
11. Duval, X; Le Moing, V; Longuet, P; Leport, C; Vilde, JL; Lamotte, C; Peytavin, G; Farinotti, R
    Efavirenz induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    X. Duval et al., "Efavirenz induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir", ANTIM AG CH, 44(9), 2000, pp. 2593-2593
12. Berlioz, F; Maoret, JJ; Paris, H; Laburthe, M; Farinotti, R; Roze, C
    alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    F. Berlioz et al., "alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line", J PHARM EXP, 294(2), 2000, pp. 466-472
13. Peytavin, G; Leng, JJ; Forestier, F; Saux, MC; Hohlfeld, P; Farinotti, R
    Placental transfer of pyrimethamine studied in an ex vivo placental perfusion model
    BIOLOGY OF THE NEONATE
    
    G. Peytavin et al., "Placental transfer of pyrimethamine studied in an ex vivo placental perfusion model", BIOL NEONAT, 78(2), 2000, pp. 83-85
14. Lamotte, C; Peytavin, G; Farinotti, R
    Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection
    JOURNAL OF CHROMATOGRAPHY B
    
    C. Lamotte et al., "Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection", J CHROMAT B, 735(2), 1999, pp. 159-170
15. Pham, YT; Nosten, F; Farinotti, R; White, NJ; Gimenez, F
    Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    
    Y.T. Pham et al., "Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria", INT J CL PH, 37(1), 1999, pp. 58-61
16. Hiep, BT; Gimenez, F; Khanh, V; Hung, NK; Thuillier, A; Farinotti, R; Fernandez, C
    Binding of chlorpheniramine enantiomers to human plasma proteins
    CHIRALITY
    
    B.T. Hiep et al., "Binding of chlorpheniramine enantiomers to human plasma proteins", CHIRALITY, 11(5-6), 1999, pp. 501-504
17. Fernandez, C; Gimenez, F; Thuillier, A; Farinotti, R
    Stereoselective binding of zopiclone to human plasma proteins
    CHIRALITY
    
    C. Fernandez et al., "Stereoselective binding of zopiclone to human plasma proteins", CHIRALITY, 11(2), 1999, pp. 129-132
18. Castela-Papin, N; Cai, S; Vatier, J; Keller, F; Souleau, CH; Farinotti, R
    Drug interactions with diosmectite: a study using the artificial stomach-duodenum model
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    N. Castela-Papin et al., "Drug interactions with diosmectite: a study using the artificial stomach-duodenum model", INT J PHARM, 182(1), 1999, pp. 111-119
19. Papin-Castela, N; Prognon, P; Keller, F; Benazeth, S; Farinotti, R; Mahuzier, G; Souleau, C
    Cerium-doped diosmectite for topical application studies of the cerium-clay interaction
    INTERNATIONAL JOURNAL OF PHARMACEUTICS
    
    N. Papin-Castela et al., "Cerium-doped diosmectite for topical application studies of the cerium-clay interaction", INT J PHARM, 181(2), 1999, pp. 193-202
20. Baune, B; Furlan, V; Taburet, AM; Farinotti, R
    Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes
    DRUG METABOLISM AND DISPOSITION
    
    B. Baune et al., "Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes", DRUG META D, 27(5), 1999, pp. 565-568
21. Wolff, M; Joly-Guillou, ML; Farinotti, R; Carbon, C
    In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    M. Wolff et al., "In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model", ANTIM AG CH, 43(6), 1999, pp. 1406-1411
22. Dautrey, S; Rabbaa, L; Laouari, D; Lacour, B; Carbon, C; Farinotti, R
    Influence of renal failure on intestinal clearance of ciprofloxacin in rats
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    S. Dautrey et al., "Influence of renal failure on intestinal clearance of ciprofloxacin in rats", ANTIM AG CH, 43(3), 1999, pp. 678-680
23. Nascimbeni, M; Lamotte, C; Peytavin, G; Farinotti, R; Clavel, F
    Kinetics of antiviral activity and intracellular pharmacokinetics of humanimmunodeficiency virus type 1 protease inhibitors in tissue culture
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    
    M. Nascimbeni et al., "Kinetics of antiviral activity and intracellular pharmacokinetics of humanimmunodeficiency virus type 1 protease inhibitors in tissue culture", ANTIM AG CH, 43(11), 1999, pp. 2629-2634
24. Baune, B; Furlan, V; Taburet, AM; Farinotti, R
    In vitro effects of racemates, separate enantiomers and major metabolites of mefloquine and halofantrine on metoprolol biotransformation by rat livermicrosomes
    XENOBIOTICA
    
    B. Baune et al., "In vitro effects of racemates, separate enantiomers and major metabolites of mefloquine and halofantrine on metoprolol biotransformation by rat livermicrosomes", XENOBIOTICA, 29(6), 1999, pp. 595-601
25. Baune, B; Flinois, JP; Furlan, V; Gimenez, F; Taburet, AM; Becquemont, L; Farinotti, R
    Halofantrine metabolism in microsomes in man: Major role of CYP 3A4 and CYP 3A5
    JOURNAL OF PHARMACY AND PHARMACOLOGY
    
    B. Baune et al., "Halofantrine metabolism in microsomes in man: Major role of CYP 3A4 and CYP 3A5", J PHARM PHA, 51(4), 1999, pp. 419-426
26. Berlioz, F; Julien, S; Tsocas, A; Chariot, J; Carbon, C; Farinotti, R; Roze, C
    Neural modulation of cephalexin intestinal absorption through the di- and tripeptide brush border transporter of rat jejunum in vivo
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    F. Berlioz et al., "Neural modulation of cephalexin intestinal absorption through the di- and tripeptide brush border transporter of rat jejunum in vivo", J PHARM EXP, 288(3), 1999, pp. 1037-1044
27. Dautrey, S; Felice, K; Petiet, A; Lacour, B; Carbon, C; Farinotti, R
    Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates
    BRITISH JOURNAL OF PHARMACOLOGY
    
    S. Dautrey et al., "Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates", BR J PHARM, 127(7), 1999, pp. 1728-1734
28. IGLARZ M; BAUNE B; GANTIER JC; HOCQUEMILLER R; FARINOTTI R
    DETERMINATION OF 2-N-PROPYLQUINOLINE IN MOUSE PLASMA AND LIVER BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    Journal of chromatography B. Biomedical sciences and applications
    
    M. Iglarz et al., "DETERMINATION OF 2-N-PROPYLQUINOLINE IN MOUSE PLASMA AND LIVER BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY", Journal of chromatography B. Biomedical sciences and applications, 714(2), 1998, pp. 335-340
29. GORICHON E; MARTIN C; BANGCHANG KN; KARBWANG J; THUILLIER A; FARINOTTI R; GIMENEZ F
    CHIRAL CHROMATOGRAPHIC METHOD TO DETERMINE THE ENANTIOMERS OF HALOFANTRINE AND ITS MAIN CHIRAL DESBUTYL METABOLITE IN ERYTHROCYTES
    Journal of chromatography B. Biomedical sciences and applications
    
    E. Gorichon et al., "CHIRAL CHROMATOGRAPHIC METHOD TO DETERMINE THE ENANTIOMERS OF HALOFANTRINE AND ITS MAIN CHIRAL DESBUTYL METABOLITE IN ERYTHROCYTES", Journal of chromatography B. Biomedical sciences and applications, 712(1-2), 1998, pp. 259-262
30. CHENEVIER P; MASSIAS L; GUEYLARD D; FARINOTTI R
    DETERMINATION OF ETHAMBUTOL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AFTER PRECOLUMN DERIVATIZATION
    Journal of chromatography B. Biomedical sciences and applications
    
    P. Chenevier et al., "DETERMINATION OF ETHAMBUTOL IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AFTER PRECOLUMN DERIVATIZATION", Journal of chromatography B. Biomedical sciences and applications, 708(1-2), 1998, pp. 310-315
31. DEROUIN F; GERARD L; FARINOTTI R; MASLO C; LEPORT C
    DETERMINATION OF THE INHIBITORY EFFECT ON TOXOPLASMA GROWTH IN THE SERUM OF AIDS PATIENTS DURING ACUTE THERAPY FOR TOXOPLASMIC ENCEPHALITIS
    Journal of acquired immune deficiency syndromes and human retrovirology
    
    F. Derouin et al., "DETERMINATION OF THE INHIBITORY EFFECT ON TOXOPLASMA GROWTH IN THE SERUM OF AIDS PATIENTS DURING ACUTE THERAPY FOR TOXOPLASMIC ENCEPHALITIS", Journal of acquired immune deficiency syndromes and human retrovirology, 19(1), 1998, pp. 50-54
32. VATIER J; CELICEPINGAUD C; FARINOTTI R
    INTERESTS OF THE ARTIFICIAL STOMACH TECHNIQUES TO STUDY ANTACID FORMULATIONS - COMPARISON WITH IN-VIVO EVALUATION
    Fundamental and clinical pharmacology
    
    J. Vatier et al., "INTERESTS OF THE ARTIFICIAL STOMACH TECHNIQUES TO STUDY ANTACID FORMULATIONS - COMPARISON WITH IN-VIVO EVALUATION", Fundamental and clinical pharmacology, 12(6), 1998, pp. 573-583
33. CARSENTIETESSE H; FARINOTTI R; DURANT J; ROGER PM; DESALVADOR F; BERNARD E; ROUVEIX B; DELLAMONICA P
    PHARMACOKINETIC PARAMETERS AND KILLING RATES IN SERUM OF VOLUNTEERS RECEIVING AMOXICILLIN, CEFADROXIL OR CEFIXIME ALONE OR ASSOCIATED WITH NIFLUMIC ACID OR PARACETAMOL
    European journal of drug metabolism and pharmacokinetics
    
    H. Carsentietesse et al., "PHARMACOKINETIC PARAMETERS AND KILLING RATES IN SERUM OF VOLUNTEERS RECEIVING AMOXICILLIN, CEFADROXIL OR CEFIXIME ALONE OR ASSOCIATED WITH NIFLUMIC ACID OR PARACETAMOL", European journal of drug metabolism and pharmacokinetics, 23(3), 1998, pp. 357-366
34. CRAUSTEMANCIET S; BROSSARD D; DECROIX MO; FARINOTTI R; CHAUMEIL JC
    CEFPODOXIME-PROXETIL PROTECTION FROM INTESTINAL LUMEN HYDROLYSIS BY OIL-IN-WATER SUBMICRON EMULSIONS
    International journal of pharmaceutics
    
    S. Craustemanciet et al., "CEFPODOXIME-PROXETIL PROTECTION FROM INTESTINAL LUMEN HYDROLYSIS BY OIL-IN-WATER SUBMICRON EMULSIONS", International journal of pharmaceutics, 165(1), 1998, pp. 97-106
35. VATIER J; CELICEPINGAUD C; FARINOTTI R
    A COMPUTERIZED ARTIFICIAL STOMACH MODEL TO ASSESS SODIUM ALGINATE-INDUCED PH GRADIENT
    International journal of pharmaceutics
    
    J. Vatier et al., "A COMPUTERIZED ARTIFICIAL STOMACH MODEL TO ASSESS SODIUM ALGINATE-INDUCED PH GRADIENT", International journal of pharmaceutics, 163(1-2), 1998, pp. 225-229
36. MASSIAS L; MULLERSERIEYS C; FARINOTTI R; BERGOGNEBEREZIN E
    PHARMACOKINETICS OF CEFUROXIME IN HEALTHY-VOLUNTEERS - AN UPDATE
    Journal of antimicrobial chemotherapy
    
    L. Massias et al., "PHARMACOKINETICS OF CEFUROXIME IN HEALTHY-VOLUNTEERS - AN UPDATE", Journal of antimicrobial chemotherapy, 42(3), 1998, pp. 408-410
37. NOUAILLEDEGORCE B; VEAU C; DAUTREY S; TOD M; LAOUARI D; CARBON C; FARINOTTI R
    INFLUENCE OF RENAL-FAILURE ON CIPROFLOXACIN PHARMACOKINETICS IN RATS
    Antimicrobial agents and chemotherapy
    
    B. Nouailledegorce et al., "INFLUENCE OF RENAL-FAILURE ON CIPROFLOXACIN PHARMACOKINETICS IN RATS", Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 289-292
38. JOINLAMBERT O; MAINARDI JL; CUVELIER C; DAUTREY S; FARINOTTI R; FANTIN B; CARBON C
    CRITICAL IMPORTANCE OF IN-VIVO AMOXICILLIN AND CEFOTAXIME CONCENTRATIONS FOR SYNERGY IN TREATMENT OF EXPERIMENTAL ENTEROCOCCUS-FAECALIS ENDOCARDITIS
    Antimicrobial agents and chemotherapy
    
    O. Joinlambert et al., "CRITICAL IMPORTANCE OF IN-VIVO AMOXICILLIN AND CEFOTAXIME CONCENTRATIONS FOR SYNERGY IN TREATMENT OF EXPERIMENTAL ENTEROCOCCUS-FAECALIS ENDOCARDITIS", Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 468-470
39. POSHO L; DELBOSBOCAGE L; GUEYLARD D; FARINOTTI R; CARBON C
    EFFECTS OF SALMONELLA-TYPHIMURIUM INFECTION AND OFLOXACIN TREATMENT ON GLUCOSE AND GLUTAMINE-METABOLISM IN CACO-2 TC-7 CELLS/
    Antimicrobial agents and chemotherapy
    
    L. Posho et al., "EFFECTS OF SALMONELLA-TYPHIMURIUM INFECTION AND OFLOXACIN TREATMENT ON GLUCOSE AND GLUTAMINE-METABOLISM IN CACO-2 TC-7 CELLS/", Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 2950-2955
40. Vatier, J; Celice-Pingaud, C; Farinotti, R
    In vitro evaluation of the antacid activity of Saint-Yorre and Vichy Celestins mineral waters in the << artificial stomach-duodenum >> model.
    ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE
    
    J. Vatier et al., "In vitro evaluation of the antacid activity of Saint-Yorre and Vichy Celestins mineral waters in the << artificial stomach-duodenum >> model.", ANN GASTRO, 34(4), 1998, pp. 157-162
41. WOLKENSTEIN P; BAUDCAMUS F; LECOEUR S; POVEDA JD; FARINOTTI R; BEAUNE P; ELIASZEWICZ M; CHOSIDOW O
    ACQUISITION OF A SLOW ACETYLATOR PHENOTYPE IN AIDS PATIENTS WITH A RAPID ACETYLATOR GENOTYPE - AN EXPLANATION FOR HIGH-FREQUENCY OF CUTANEOUS SULFONAMIDES REACTIONS IN AIDS
    Journal of investigative dermatology
    
    P. Wolkenstein et al., "ACQUISITION OF A SLOW ACETYLATOR PHENOTYPE IN AIDS PATIENTS WITH A RAPID ACETYLATOR GENOTYPE - AN EXPLANATION FOR HIGH-FREQUENCY OF CUTANEOUS SULFONAMIDES REACTIONS IN AIDS", Journal of investigative dermatology, 110(4), 1998, pp. 681-681
42. CUVELIER AC; BERLIOZ F; DAUTREY SC; ROZE C; CARBON C; FARINOTTI R
    INTESTINAL-ABSORPTION OF SAQUINAVIR IN THE RAT - INSIGHTS IN POSSIBLEMECHANISMS
    Gastroenterology
    
    A.C. Cuvelier et al., "INTESTINAL-ABSORPTION OF SAQUINAVIR IN THE RAT - INSIGHTS IN POSSIBLEMECHANISMS", Gastroenterology, 114(4), 1998, pp. 3926-3926
43. LANGOUET AM; SIMON D; BRICE P; REYES F; SALLES G; TILLY H; FARINOTTI R; FAURE P; LEPAGE E; GISSELBRECHT C
    FACTORS INFLUENCING HEMATOLOGIC RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN AGGRESSIVE NON-HODGKINS-LYMPHOMA
    British Journal of Haematology
    
    A.M. Langouet et al., "FACTORS INFLUENCING HEMATOLOGIC RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN AGGRESSIVE NON-HODGKINS-LYMPHOMA", British Journal of Haematology, 102(1), 1998, pp. 206-206
44. FARINOTTI R; FERRARINI M; SOLARI A; FILIPPINI G
    INCIDENCE AND SURVIVAL OF CHILDHOOD CNS TUMORS IN THE REGION OF LOMBARDY, ITALY
    Brain (Print)
    
    R. Farinotti et al., "INCIDENCE AND SURVIVAL OF CHILDHOOD CNS TUMORS IN THE REGION OF LOMBARDY, ITALY", Brain (Print), 121, 1998, pp. 1429-1436
45. DUCHARME J; FARINOTTI R
    RAPID AND SIMPLE METHOD TO DETERMINE CHLOROQUINE AND ITS DESETHYLATEDMETABOLITES IN HUMAN MICROSOMES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
    Journal of chromatography B. Biomedical sciences and applications
    
    J. Ducharme e R. Farinotti, "RAPID AND SIMPLE METHOD TO DETERMINE CHLOROQUINE AND ITS DESETHYLATEDMETABOLITES IN HUMAN MICROSOMES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION", Journal of chromatography B. Biomedical sciences and applications, 698(1-2), 1997, pp. 243-250
46. VATIER J; CAI S; CELICEPINGAUD C; LENOT P; GLEIZES S; TOSELLI D; FARINOTTI R
    INTEREST OF THE ARTIFICIAL STOMACH-DUODENUM MODEL FOR IN-VITRO EVALUATION OF THE ACTIVITY OF ENZYMES CONTAINED IN GALENIC FORMS
    STP pharma sciences
    
    J. Vatier et al., "INTEREST OF THE ARTIFICIAL STOMACH-DUODENUM MODEL FOR IN-VITRO EVALUATION OF THE ACTIVITY OF ENZYMES CONTAINED IN GALENIC FORMS", STP pharma sciences, 7(2), 1997, pp. 123-128
47. GIMENEZ F; SOURSAC M; FARINOTTI R
    ENANTIOMERIC SEPARATION OF 5 AMINO-ACIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON A CHIRAL CROWN-ETHER COLUMN
    Chirality
    
    F. Gimenez et al., "ENANTIOMERIC SEPARATION OF 5 AMINO-ACIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ON A CHIRAL CROWN-ETHER COLUMN", Chirality, 9(2), 1997, pp. 150-152
48. CRAUSTEMANCIET S; DECROIX MO; FARINOTTI R; CHAUMEIL JC
    CEFPODOXIME-PROXETIL HYDROLYSIS AND FOOD EFFECTS IN THE INTESTINAL LUMEN BEFORE ABSORPTION - IN-VITRO COMPARISON OF RABBIT AND HUMAN MATERIAL
    International journal of pharmaceutics
    
    S. Craustemanciet et al., "CEFPODOXIME-PROXETIL HYDROLYSIS AND FOOD EFFECTS IN THE INTESTINAL LUMEN BEFORE ABSORPTION - IN-VITRO COMPARISON OF RABBIT AND HUMAN MATERIAL", International journal of pharmaceutics, 157(2), 1997, pp. 153-161
49. CRAUSTEMANCIET S; HUNEAU JF; DECROIX MO; TOME D; FARINOTTI R; CHAUMEIL JC
    CEFPODOXIME PROXETIL ESTERASE-ACTIVITY IN RABBIT SMALL-INTESTINE - A ROLE IN THE PARTIAL CEFPODOXIME ABSORPTION
    International journal of pharmaceutics
    
    S. Craustemanciet et al., "CEFPODOXIME PROXETIL ESTERASE-ACTIVITY IN RABBIT SMALL-INTESTINE - A ROLE IN THE PARTIAL CEFPODOXIME ABSORPTION", International journal of pharmaceutics, 149(2), 1997, pp. 241-249
50. SOGNI P; HADENGUE A; MOREAU R; LEMOINE O; SOUPISON T; OBERTI F; FARINOTTI R; LEBREC D
    ACUTE EFFECTS OF PROPYLTHIOURACIL ON HEMODYNAMICS AND OXYGEN-CONTENT IN PATIENTS WITH ALCOHOLIC CIRRHOSIS
    Journal of hepatology
    
    P. Sogni et al., "ACUTE EFFECTS OF PROPYLTHIOURACIL ON HEMODYNAMICS AND OXYGEN-CONTENT IN PATIENTS WITH ALCOHOLIC CIRRHOSIS", Journal of hepatology, 26(3), 1997, pp. 628-633
51. RABBAA L; DAUTREY S; COLASLINHART N; CARBON C; FARINOTTI R
    ABSORPTION OF OFLOXACIN ISOMERS IN THE RAT SMALL-INTESTINE
    Antimicrobial agents and chemotherapy
    
    L. Rabbaa et al., "ABSORPTION OF OFLOXACIN ISOMERS IN THE RAT SMALL-INTESTINE", Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2274-2277
52. BAUDRY S; PHAM YT; BAUNE B; VIDREQUIN S; CREVOISIER C; GIMENEZ F; FARINOTTI R
    STEREOSELECTIVE PASSAGE OF MEFLOQUINE THROUGH THE BLOOD-BRAIN-BARRIERIN THE RAT
    Journal of Pharmacy and Pharmacology
    
    S. Baudry et al., "STEREOSELECTIVE PASSAGE OF MEFLOQUINE THROUGH THE BLOOD-BRAIN-BARRIERIN THE RAT", Journal of Pharmacy and Pharmacology, 49(11), 1997, pp. 1086-1090
53. HARCOUET L; LEBREC D; ROZE C; CARBON C; FARINOTTI R
    INCREASED INTESTINAL-ABSORPTION OF CEFIXIME BY NIFEDIPINE IN THE RAT INTESTINAL PERFUSION MODEL - EVIDENCE FOR A NEURAL REGULATION
    The Journal of pharmacology and experimental therapeutics
    
    L. Harcouet et al., "INCREASED INTESTINAL-ABSORPTION OF CEFIXIME BY NIFEDIPINE IN THE RAT INTESTINAL PERFUSION MODEL - EVIDENCE FOR A NEURAL REGULATION", The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 738-745
54. BERLIOZ F; JULIEN S; TSOCAS A; CHARIOT J; ROZE C; FARINOTTI R
    NEURAL MODULATION OF JEJUNAL-ABSORPTION OF THE PEPTIDOMIMETIC DRUG CEPHALEXIN IN THE RAT
    Gastroenterology
    
    F. Berlioz et al., "NEURAL MODULATION OF JEJUNAL-ABSORPTION OF THE PEPTIDOMIMETIC DRUG CEPHALEXIN IN THE RAT", Gastroenterology, 112(4), 1997, pp. 348-348
55. VEYRATFOLLET C; FARINOTTI R; PALMER JL
    PHYSIOLOGY OF CHEMOTHERAPY-INDUCED EMESIS AND ANTIEMETIC THERAPY - PREDICTIVE MODELS FOR EVALUATION OF NEW COMPOUNDS
    Drugs
    
    C. Veyratfollet et al., "PHYSIOLOGY OF CHEMOTHERAPY-INDUCED EMESIS AND ANTIEMETIC THERAPY - PREDICTIVE MODELS FOR EVALUATION OF NEW COMPOUNDS", Drugs, 53(2), 1997, pp. 206-234
56. DUCHARME J; FLINOIS JP; BAUNE B; FARINOTTI R; BEAUNE P
    MIDAZOLAM (MDZ) HYDROXYLATION IN YEAST-EXPRESSED CYPS
    Clinical pharmacology and therapeutics
    
    J. Ducharme et al., "MIDAZOLAM (MDZ) HYDROXYLATION IN YEAST-EXPRESSED CYPS", Clinical pharmacology and therapeutics, 61(2), 1997, pp. 68-68
57. BOUGEOIS B; SERVIN F; MASSIAS L; FARINOTTI R; DESMONTS JM
    A PHARMACOKINETIC AND DYNAMIC STUDY OF PROPOFOL INFUSION IN ALCOHOLICPATIENTS
    Anesthesiology
    
    B. Bougeois et al., "A PHARMACOKINETIC AND DYNAMIC STUDY OF PROPOFOL INFUSION IN ALCOHOLICPATIENTS", Anesthesiology, 87(3), 1997, pp. 312-312
58. SERVIN F; LAVAUT E; PEYTAVIN G; FARINOTTI R; DESMONTS JM
    A PHARMACOKINETIC AND DYNAMIC STUDY OF MIVACURIUM INFUSION IN ELDERLYPATIENTS
    Anesthesiology
    
    F. Servin et al., "A PHARMACOKINETIC AND DYNAMIC STUDY OF MIVACURIUM INFUSION IN ELDERLYPATIENTS", Anesthesiology, 87(3), 1997, pp. 855-855
59. DUCHARME J; FERNANDEZ C; GIMENEZ F; FARINOTTI R
    CRITICAL ISSUES IN CHIRAL DRUG ANALYSIS IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    Journal of chromatography B. Biomedical applications
    
    J. Ducharme et al., "CRITICAL ISSUES IN CHIRAL DRUG ANALYSIS IN BIOLOGICAL-FLUIDS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY", Journal of chromatography B. Biomedical applications, 686(1), 1996, pp. 65-75
60. BRUNPASCAUD M; CHAU F; GARRY L; FARINOTTI R; DEROUIN F; GIRARD PM
    ALTERED TRIMETHOPRIM-SULFAMETHOXAZOLE RATIOS FOR PROPHYLAXIS AND TREATMENT OF TOXOPLASMA-GONDII AND PNEUMOCYSTIS-CARINII DUAL INFECTIONS INRAT MODEL
    Journal of acquired immune deficiency syndromes and human retrovirology
    
    M. Brunpascaud et al., "ALTERED TRIMETHOPRIM-SULFAMETHOXAZOLE RATIOS FOR PROPHYLAXIS AND TREATMENT OF TOXOPLASMA-GONDII AND PNEUMOCYSTIS-CARINII DUAL INFECTIONS INRAT MODEL", Journal of acquired immune deficiency syndromes and human retrovirology, 13(3), 1996, pp. 201-207
61. VATIER J; RIQUET W; CELICEPINGAUD C; OLIVIER A; MIGNON M; FARINOTTI R
    EFFECT ON GASTRIC-SECRETION, GASTRIN AND HISTAMINE-RELEASE DURING ANDAFTER LONG-TERM TREATMENT BY PIRENZEPINE IN DOGS
    Fundamental and clinical pharmacology
    
    J. Vatier et al., "EFFECT ON GASTRIC-SECRETION, GASTRIN AND HISTAMINE-RELEASE DURING ANDAFTER LONG-TERM TREATMENT BY PIRENZEPINE IN DOGS", Fundamental and clinical pharmacology, 10(2), 1996, pp. 144-150
62. FAURISSON F; DESSANGES JF; GRIMFELD A; BEAULIEU R; KITZIS MD; PEYTAVIN G; LEFEVRE JP; FARINOTTI R; SAUTEGEAU A
    PERFORMANCES AND ERGONOMICS OF NEBULIZERS IN CYSTIC-FIBROSIS
    Revue des maladies respiratoires
    
    F. Faurisson et al., "PERFORMANCES AND ERGONOMICS OF NEBULIZERS IN CYSTIC-FIBROSIS", Revue des maladies respiratoires, 13(2), 1996, pp. 155-162
63. DUCHARME J; FARINOTTI R
    CLINICAL PHARMACOKINETICS AND METABOLISM OF CHLOROQUINE - FOCUS ON RECENT ADVANCEMENTS
    Clinical pharmacokinetics
    
    J. Ducharme e R. Farinotti, "CLINICAL PHARMACOKINETICS AND METABOLISM OF CHLOROQUINE - FOCUS ON RECENT ADVANCEMENTS", Clinical pharmacokinetics, 31(4), 1996, pp. 257-274
64. VIDREQUIN S; GIMENEZ F; BASCO LK; MARTIN C; LEBRAS J; FARINOTTI R
    UPTAKE OF MEFLOQUINE ENANTIOMERS INTO UNINFECTED AND MALARIA-INFECTEDERYTHROCYTES
    Drug metabolism and disposition
    
    S. Vidrequin et al., "UPTAKE OF MEFLOQUINE ENANTIOMERS INTO UNINFECTED AND MALARIA-INFECTEDERYTHROCYTES", Drug metabolism and disposition, 24(6), 1996, pp. 689-691
65. ROMAND S; DELLABRUNA C; FARINOTTI R; DEROUIN F
    IN-VITRO AND IN-VIVO EFFECTS OF RIFABUTIN ALONE OR COMBINED WITH ATOVAQUONE AGAINST TOXOPLASMA-GONDII
    Antimicrobial agents and chemotherapy
    
    S. Romand et al., "IN-VITRO AND IN-VIVO EFFECTS OF RIFABUTIN ALONE OR COMBINED WITH ATOVAQUONE AGAINST TOXOPLASMA-GONDII", Antimicrobial agents and chemotherapy, 40(9), 1996, pp. 2015-2020
66. RABBAA L; DAUTREY S; COLASLINHART N; CARBON C; FARINOTTI R
    INTESTINAL ELIMINATION OF OFLOXACIN ENANTIOMERS IN THE RAT - EVIDENCEOF A CARRIER-MEDIATED PROCESS
    Antimicrobial agents and chemotherapy
    
    L. Rabbaa et al., "INTESTINAL ELIMINATION OF OFLOXACIN ENANTIOMERS IN THE RAT - EVIDENCEOF A CARRIER-MEDIATED PROCESS", Antimicrobial agents and chemotherapy, 40(9), 1996, pp. 2126-2130
67. GANGNEUX JP; SULAHIAN A; GARIN YJF; FARINOTTI R; DEROUIN F
    THERAPY OF VISCERAL LEISHMANIASIS DUE TO LEISHMANIA-INFANTUM - EXPERIMENTAL ASSESSMENT OF EFFICACY OF AMBISOME
    Antimicrobial agents and chemotherapy
    
    J.P. Gangneux et al., "THERAPY OF VISCERAL LEISHMANIASIS DUE TO LEISHMANIA-INFANTUM - EXPERIMENTAL ASSESSMENT OF EFFICACY OF AMBISOME", Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1214-1218
68. FANTIN B; PIERRE J; CASTELAPAPIN N; SAINTJULIEN L; DRUGEON H; FARINOTTI R; CARBON C
    IMPORTANCE OF PENICILLINASE PRODUCTION FOR ACTIVITY OF PENICILLIN ALONE OR IN COMBINATION WITH SULBACTAM IN EXPERIMENTAL ENDOCARDITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    Antimicrobial agents and chemotherapy
    
    B. Fantin et al., "IMPORTANCE OF PENICILLINASE PRODUCTION FOR ACTIVITY OF PENICILLIN ALONE OR IN COMBINATION WITH SULBACTAM IN EXPERIMENTAL ENDOCARDITIS DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS", Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1219-1224
69. DESLANDES A; CAMUS F; LACROIX C; CARBON C; FARINOTTI R
    EFFECTS OF NIFEDIPINE AND DILTIAZEM ON PHARMACOKINETICS OF CEFPODOXIME FOLLOWING ITS ORAL-ADMINISTRATION
    Antimicrobial agents and chemotherapy
    
    A. Deslandes et al., "EFFECTS OF NIFEDIPINE AND DILTIAZEM ON PHARMACOKINETICS OF CEFPODOXIME FOLLOWING ITS ORAL-ADMINISTRATION", Antimicrobial agents and chemotherapy, 40(12), 1996, pp. 2879-2881
70. CHEMLAL K; SAINTJULIEN L; JOLY V; FARINOTTI R; SETA N; YENI P; CARBON C
    COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR TREATMENT OF EXPERIMENTAL CANDIDA-ALBICANS ENDOCARDITIS IN RABBITS
    Antimicrobial agents and chemotherapy
    
    K. Chemlal et al., "COMPARISON OF FLUCONAZOLE AND AMPHOTERICIN-B FOR TREATMENT OF EXPERIMENTAL CANDIDA-ALBICANS ENDOCARDITIS IN RABBITS", Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 263-266
71. VATIER J; CAI S; SLAMA A; FARINOTTI R
    ANTACID ACTIVITY OF CITRATE-BICARBONATE C OMPLEX OF EFFERVESCENT FORMULATIONS OF RANITIDINE, IN-VITRO EVALUATION USING THE ARTIFICIAL STOMACH-DUODENUM MODEL
    Therapie
    
    J. Vatier et al., "ANTACID ACTIVITY OF CITRATE-BICARBONATE C OMPLEX OF EFFERVESCENT FORMULATIONS OF RANITIDINE, IN-VITRO EVALUATION USING THE ARTIFICIAL STOMACH-DUODENUM MODEL", Therapie, 51(2), 1996, pp. 139-146
72. VATIER J; CAI S; CELICEPINGAUD C; CASTELAPAPIN N; MIGNON M; FARINOTTI R
    IN-VITRO ASSESSMENT OF ANTACID EFFICACY USING A COMPUTER-CONTROLLED ARTIFICIAL STOMACH-DUODENUM MODEL REPRODUCING GASTRODUODENAL FLUX REGULATION
    Therapie
    
    J. Vatier et al., "IN-VITRO ASSESSMENT OF ANTACID EFFICACY USING A COMPUTER-CONTROLLED ARTIFICIAL STOMACH-DUODENUM MODEL REPRODUCING GASTRODUODENAL FLUX REGULATION", Therapie, 51(2), 1996, pp. 147-154
73. BOURAHLA A; MARTIN C; GIMENEZ F; SINGHASIVANON V; ATTANATH P; SABCHEARON A; CHONGSUPHAJAISIDDHI T; FARINOTTI R
    STEREOSELECTIVE PHARMACOKINETICS OF MEFLOQUINE IN YOUNG-CHILDREN
    European Journal of Clinical Pharmacology
    
    A. Bourahla et al., "STEREOSELECTIVE PHARMACOKINETICS OF MEFLOQUINE IN YOUNG-CHILDREN", European Journal of Clinical Pharmacology, 50(3), 1996, pp. 241-244
74. DELARMINAT V; BOCZKOWSKI J; DUREUIL B; VICAUT E; FARINOTTI R; AUBIER M; DESMONTS JM
    ROLE OF PROSTAGLANDINS AND NITRIC-OXIDE ON HALOTHANE-INDUCED ARTERIOLAR DILATATION IN RAT DIAPHRAGM
    British Journal of Anaesthesia
    
    V. Delarminat et al., "ROLE OF PROSTAGLANDINS AND NITRIC-OXIDE ON HALOTHANE-INDUCED ARTERIOLAR DILATATION IN RAT DIAPHRAGM", British Journal of Anaesthesia, 77(2), 1996, pp. 232-237
75. MURAT I; BILLARD V; VERNOIS J; ZAOUTER M; MARSOL P; SOURON R; FARINOTTI R
    PHARMACOKINETICS OF PROPOFOL AFTER A SINGLE-DOSE IN CHILDREN AGED 1-3YEARS WITH MINOR BURNS - COMPARISON OF 3 DATA-ANALYSIS APPROACHES
    Anesthesiology
    
    I. Murat et al., "PHARMACOKINETICS OF PROPOFOL AFTER A SINGLE-DOSE IN CHILDREN AGED 1-3YEARS WITH MINOR BURNS - COMPARISON OF 3 DATA-ANALYSIS APPROACHES", Anesthesiology, 84(3), 1996, pp. 526-532
76. NATTOUF H; DAVRINCHE C; SINET M; FARINOTTI R
    HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR 3'-AMINO-3'-DEOXYTHYMIDINE IN PLASMA, WITH 9-FLUORENYL METHYL CHLOROFORMATE AS THE DERIVATIZATION AGENT
    Journal of chromatography B. Biomedical applications
    
    H. Nattouf et al., "HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR 3'-AMINO-3'-DEOXYTHYMIDINE IN PLASMA, WITH 9-FLUORENYL METHYL CHLOROFORMATE AS THE DERIVATIZATION AGENT", Journal of chromatography B. Biomedical applications, 664(2), 1995, pp. 365-371
77. FERNANDEZ C; GIMENEZ F; MAYRARGUE J; THUILLIER A; FARINOTTI R
    DEGRADATION AND RACEMIZATION OF ZOPICLONE ENANTIOMERS IN PLASMA AND PARTIALLY AQUEOUS-SOLUTIONS
    Chirality
    
    C. Fernandez et al., "DEGRADATION AND RACEMIZATION OF ZOPICLONE ENANTIOMERS IN PLASMA AND PARTIALLY AQUEOUS-SOLUTIONS", Chirality, 7(4), 1995, pp. 267-271
78. FERNANDEZ C; MARTIN C; GIMENEZ F; FARINOTTI R
    CLINICAL PHARMACOKINETICS OF ZOPICLONE
    Clinical pharmacokinetics
    
    C. Fernandez et al., "CLINICAL PHARMACOKINETICS OF ZOPICLONE", Clinical pharmacokinetics, 29(6), 1995, pp. 431-441
79. FAURISSON F; DESSANGES JF; GRIMFELD A; BEAULIEU R; KITZIS MD; PEYTAVIN G; LEFEBVRE JP; FARINOTTI R; SAUTEGEAU A
    NEBULIZER PERFORMANCE - AFLM STUDY
    Respiration
    
    F. Faurisson et al., "NEBULIZER PERFORMANCE - AFLM STUDY", Respiration, 62, 1995, pp. 13-18
80. PEYTAVIN G; FARINOTTI R; REVUZ J; ROUJEAU JC; CHOSIDOW O
    NORMAL PLASMATIC LEVELS OF SULFONAMIDES IN SULFONAMIDE-INDUCED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS
    Journal of investigative dermatology
    
    G. Peytavin et al., "NORMAL PLASMATIC LEVELS OF SULFONAMIDES IN SULFONAMIDE-INDUCED STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS", Journal of investigative dermatology, 105(3), 1995, pp. 478-478
81. NGUYEN HN; LOUVILLE Y; FARINOTTI R; CAZALAA JB; ATINAULT A; TROUVIN JH; BAILLET A; COSTE JL; BARRIER G
    USING SUBDELTA WAVES TO GUIDE PROPOFOL INFUSION
    Anesthesiology
    
    H.N. Nguyen et al., "USING SUBDELTA WAVES TO GUIDE PROPOFOL INFUSION", Anesthesiology, 83(3A), 1995, pp. 502-502
82. MURAT I; ZAOUTER M; GRANADOS M; SOURON R; FARINOTTI R
    PHARMACOKINETICS OF PROPOFOL CHILDREN UNDER 3 YEARS OF AGE
    Anesthesiology
    
    I. Murat et al., "PHARMACOKINETICS OF PROPOFOL CHILDREN UNDER 3 YEARS OF AGE", Anesthesiology, 83(3A), 1995, pp. 1131-1131
83. CAMUS F; DESLANDES A; HARCOUET L; FARINOTTI R
    HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF CEFPODOXIME LEVELS IN PLASMA AND SINUS MUCOSA
    Journal of chromatography B. Biomedical applications
    
    F. Camus et al., "HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF CEFPODOXIME LEVELS IN PLASMA AND SINUS MUCOSA", Journal of chromatography B. Biomedical applications, 656(2), 1994, pp. 383-388
84. FANTIN B; FARINOTTI R; THABAUT A; CARBON C
    CONDITIONS FOR THE EMERGENCE OF RESISTANCE TO CEFPIROME AND CEFTAZIDIME IN EXPERIMENTAL ENDOCARDITIS DUE TO PSEUDOMONAS-AERUGINOSA
    Journal of antimicrobial chemotherapy
    
    B. Fantin et al., "CONDITIONS FOR THE EMERGENCE OF RESISTANCE TO CEFPIROME AND CEFTAZIDIME IN EXPERIMENTAL ENDOCARDITIS DUE TO PSEUDOMONAS-AERUGINOSA", Journal of antimicrobial chemotherapy, 33(3), 1994, pp. 563-569
85. BASCO LK; PEYTAVIN G; GIMENEZ F; GENISSEL B; FARINOTTI R; LEBRAS J
    IN-VITRO ACTIVITY OF THE ENANTIOMERS OF N-DESBUTYL DERIVATIVE OF HALOFANTRINE
    Tropical medicine and parasitology
    
    L.K. Basco et al., "IN-VITRO ACTIVITY OF THE ENANTIOMERS OF N-DESBUTYL DERIVATIVE OF HALOFANTRINE", Tropical medicine and parasitology, 45(1), 1994, pp. 45-46
86. JOLY V; FARINOTTI R; SAINTJULIEN L; CHERON M; CARBON C; YENI P
    IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID
    Antimicrobial agents and chemotherapy
    
    V. Joly et al., "IN-VITRO RENAL TOXICITY AND IN-VIVO THERAPEUTIC EFFICACY IN EXPERIMENTAL MURINE CRYPTOCOCCOSIS OF AMPHOTERICIN-B (FUNGIZONE) ASSOCIATED WITH INTRALIPID", Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 177-183
87. MARTIN C; GIMENEZ F; BANGCHANG KN; KARBWANG J; WAINER IW; FARINOTTI R
    WHOLE-BLOOD CONCENTRATIONS OF MEFLOQUINE ENANTIOMERS IN HEALTHY THAI VOLUNTEERS
    European Journal of Clinical Pharmacology
    
    C. Martin et al., "WHOLE-BLOOD CONCENTRATIONS OF MEFLOQUINE ENANTIOMERS IN HEALTHY THAI VOLUNTEERS", European Journal of Clinical Pharmacology, 47(1), 1994, pp. 85-87
88. GIMENEZ F; GILLOTIN C; BASCO LK; BOUCHAUD O; AUBRY AF; WAINER IW; LEBRAS J; FARINOTTI R
    PLASMA-CONCENTRATIONS OF THE ENANTIOMERS OF HALOFANTRINE AND ITS MAINMETABOLITE IN MALARIA PATIENTS
    European Journal of Clinical Pharmacology
    
    F. Gimenez et al., "PLASMA-CONCENTRATIONS OF THE ENANTIOMERS OF HALOFANTRINE AND ITS MAINMETABOLITE IN MALARIA PATIENTS", European Journal of Clinical Pharmacology, 46(6), 1994, pp. 561-562
89. VATIER J; HARMAN A; CASTELA N; DROYLEFAIX MT; FARINOTTI R
    INTERACTIONS OF CIMETIDINE AND RANITIDINE WITH ALUMINUM-CONTAINING ANTACIDS AND A CLAY-CONTAINING GASTRIC-PROTECTIVE DRUG IN AN ARTIFICIAL STOMACH-DUODENUM MODEL
    Journal of pharmaceutical sciences
    
    J. Vatier et al., "INTERACTIONS OF CIMETIDINE AND RANITIDINE WITH ALUMINUM-CONTAINING ANTACIDS AND A CLAY-CONTAINING GASTRIC-PROTECTIVE DRUG IN AN ARTIFICIAL STOMACH-DUODENUM MODEL", Journal of pharmaceutical sciences, 83(7), 1994, pp. 962-966
90. GIMENEZ F; PENNIE RA; KOREN G; CREVOISIER C; WAINER IW; FARINOTTI R
    STEREOSELECTIVE PHARMACOKINETICS OF MEFLOQUINE IN HEALTHY CAUCASIANS AFTER MULTIPLE DOSES
    Journal of pharmaceutical sciences
    
    F. Gimenez et al., "STEREOSELECTIVE PHARMACOKINETICS OF MEFLOQUINE IN HEALTHY CAUCASIANS AFTER MULTIPLE DOSES", Journal of pharmaceutical sciences, 83(6), 1994, pp. 824-827
91. MAINARDI JL; ZHOU XY; GOLDSTEIN F; MOHLER J; FARINOTTI R; GUTMANN L; CARBON C
    ACTIVITY OF ISEPAMICIN AND SELECTION OF PERMEABILITY MUTANTS TO BETA-LACTAMS DURING AMINOGLYCOSIDE THERAPY OF EXPERIMENTAL ENDOCARDITIS DUETO KLEBSIELLA-PNEUMONIAE-CF104 PRODUCING AN AMINOGLYCOSIDE ACETYLTRANSFERASE 6' MODIFYING ENZYME AND A TEM-3 BETA-LACTAMASE
    The Journal of infectious diseases
    
    J.L. Mainardi et al., "ACTIVITY OF ISEPAMICIN AND SELECTION OF PERMEABILITY MUTANTS TO BETA-LACTAMS DURING AMINOGLYCOSIDE THERAPY OF EXPERIMENTAL ENDOCARDITIS DUETO KLEBSIELLA-PNEUMONIAE-CF104 PRODUCING AN AMINOGLYCOSIDE ACETYLTRANSFERASE 6' MODIFYING ENZYME AND A TEM-3 BETA-LACTAMASE", The Journal of infectious diseases, 169(6), 1994, pp. 1318-1324
92. RUBINSTEIN E; STJULIEN L; RAMON J; DAUTREY S; FARINOTTI R; HUNEAU JF; CARBON C
    THE INTESTINAL ELIMINATION OF CIPROFLOXACIN IN THE RAT
    The Journal of infectious diseases
    
    E. Rubinstein et al., "THE INTESTINAL ELIMINATION OF CIPROFLOXACIN IN THE RAT", The Journal of infectious diseases, 169(1), 1994, pp. 218-221
93. MASSIAS L; BUFFE P; COHEN B; CUDENNEC Y; GEHANNO P; STERKERS O; FARINOTTI R
    STUDY OF THE DISTRIBUTION OF ORAL CIPROFLOXACIN INTO THE MUCOSA OF THE MIDDLE-EAR AND THE CORTICAL BONE OF THE MASTOID PROCESS
    Chemotherapy
    
    L. Massias et al., "STUDY OF THE DISTRIBUTION OF ORAL CIPROFLOXACIN INTO THE MUCOSA OF THE MIDDLE-EAR AND THE CORTICAL BONE OF THE MASTOID PROCESS", Chemotherapy, 40, 1994, pp. 3-7
94. FASSOULAKI A; FARINOTTI R; MANTZ J; DESMONTS JM
    DOES TOLERANCE DEVELOP TO THE ANESTHETIC EFFECTS OF PROPOFOL IN RATS
    British Journal of Anaesthesia
    
    A. Fassoulaki et al., "DOES TOLERANCE DEVELOP TO THE ANESTHETIC EFFECTS OF PROPOFOL IN RATS", British Journal of Anaesthesia, 72(1), 1994, pp. 127-128
95. VEYSSIER P; CEVALLOS R; FOUILLERIBEYRE CL; GEFFRAY L; KALOUSTIAN E; FARINOTTI R
    SAFETY OF PENTAMIDINE PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA ON THE ENDOCRINE PANCREATIC FUNCTION IN HIV PATIENTS
    Annales de medecine interne
    
    P. Veyssier et al., "SAFETY OF PENTAMIDINE PROPHYLAXIS FOR PNEUMOCYSTIS-CARINII PNEUMONIA ON THE ENDOCRINE PANCREATIC FUNCTION IN HIV PATIENTS", Annales de medecine interne, 145(7), 1994, pp. 464-466
96. BOUCHAUD O; BASCO LK; GILLOTIN C; GIMENEZ F; RAMILIARISOA O; GENISSEL B; BOUVET E; FARINOTTI R; LEBRAS J; COULAUD JP
    CLINICAL EFFICACY AND PHARMACOKINETICS OF MICRONIZED HALOFANTRINE FORTHE TREATMENT OF ACUTE UNCOMPLICATED FALCIPARUM-MALARIA IN NONIMMUNE PATIENTS
    The American journal of tropical medicine and hygiene
    
    O. Bouchaud et al., "CLINICAL EFFICACY AND PHARMACOKINETICS OF MICRONIZED HALOFANTRINE FORTHE TREATMENT OF ACUTE UNCOMPLICATED FALCIPARUM-MALARIA IN NONIMMUNE PATIENTS", The American journal of tropical medicine and hygiene, 51(2), 1994, pp. 204-213
97. BINGEN E; DOIT C; FARINOTTI R; LAMBERTZECHOVSKY N
    KILLING KINETICS OF CEFUROXIME AGAINST STREPTOCOCCUS-PNEUMONIAE IN ANINVITRO MODEL SIMULATING SERUM CONCENTRATION PROFILES AFTER INTRAMUSCULAR ADMINISTRATION
    European journal of clinical microbiology & infectious diseases
    
    E. Bingen et al., "KILLING KINETICS OF CEFUROXIME AGAINST STREPTOCOCCUS-PNEUMONIAE IN ANINVITRO MODEL SIMULATING SERUM CONCENTRATION PROFILES AFTER INTRAMUSCULAR ADMINISTRATION", European journal of clinical microbiology & infectious diseases, 12(4), 1993, pp. 297-299
98. PEYTAVIN G; GIMENEZ F; GENISSEL B; GILLOTIN C; BAILLET A; WAINER IW; FARINOTTI R
    CHIRAL RESOLUTION OF SOME ANTIMALARIAL AGENTS BY SUBCRITICAL AND SUPERCRITICAL-FLUID CHROMATOGRAPHY ON AN (S)-NAPHTHYLUREA STATIONARY-PHASE
    Chirality
    
    G. Peytavin et al., "CHIRAL RESOLUTION OF SOME ANTIMALARIAL AGENTS BY SUBCRITICAL AND SUPERCRITICAL-FLUID CHROMATOGRAPHY ON AN (S)-NAPHTHYLUREA STATIONARY-PHASE", Chirality, 5(3), 1993, pp. 173-180
99. CHOSSON E; UZAN S; GIMENEZ F; WAINER IW; FARINOTTI R
    INFLUENCE OF SPECIFIC ALBUMIN LIGAND MARKERS USED AS MODIFIERS ON THESEPARATION OF BENZODIAZEPINE ENANTIOMERS BY CHIRAL LIQUID-CHROMATOGRAPHY ON A HUMAN SERUM-ALBUMIN COLUMN
    Chirality
    
    E. Chosson et al., "INFLUENCE OF SPECIFIC ALBUMIN LIGAND MARKERS USED AS MODIFIERS ON THESEPARATION OF BENZODIAZEPINE ENANTIOMERS BY CHIRAL LIQUID-CHROMATOGRAPHY ON A HUMAN SERUM-ALBUMIN COLUMN", Chirality, 5(2), 1993, pp. 71-77
100. MASSIAS L; BUFFE P; COHEN B; CUDENNEC Y; GEHANNO P; STERKERS O; FARINOTTI R
     ORAL CIPROFLOXACIN DIFFUSION INTO MIDDLE- EAR MUCOSA AND MASTOID CORTICAL BONE
     Medecine et maladies infectieuses
     
     L. Massias et al., "ORAL CIPROFLOXACIN DIFFUSION INTO MIDDLE- EAR MUCOSA AND MASTOID CORTICAL BONE", Medecine et maladies infectieuses, 23, 1993, pp. 3-7